A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting
Sponsored by Tianjin Medical University Cancer Institute and Hospital
About this trial
Last updated 3 years ago
Study ID
ZC20009
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All Sexes
Trial Timing
Ended 3 years ago
What is this trial about?
The goal of this clinical trial is to investigate the effect of a nurse-led standardized intervention on chemotherapy induced nausea and vomiting (CINV) in patients with head and neck squamous cell carcinoma. The main questions it aims to answer are: (1) what's the best practice to enhance the management of CINV; (2) how's the effect of the nurse-led standardized intervention on CINV in the patients treated with cisplatin-based chemotherapy. Participants in the intervention group will receive evidence-based, nurse-led standardized management of CINV, including nurse-led risk assessment, education on prevention and control of CINV, antiemetics following guidelines, dietary strategies, relaxation therapy, and follow up. Participants in the control group will receive routine care of CINV. The incidence and occurrence degree of CINV and its influence on patients' quality of life will be compared between the two groups.
What are the participation requirements?
Inclusion Criteria
* diagnosed with head and neck squamous cell carcinoma
* receive first cycle of chemotherapy
* receive cisplatin-based chemotherapy
* able to read and write.
Exclusion Criteria
* experience nausea or vomiting in 24 hours before receiving chemotherapy
* mental disturbance
* disturbance of consciousness
* history of stomach disease or surgery.